Stay updated with breaking news from Sarepta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Antisense & RNAi Therapeutics Global Market Report 2022: By Technology, By Route, By Indication" report has been added to...
Global Gene and Cell Therapies Targeting CNS Disorders Market | Key players are Helminth, Rapa Therapeutics, Brainstorm Cell Therapeutics, Neuroblast, Ost
The constant gang violence shootings claiming lives of children in gang hotspots have parallels with the recent Texas school massacre.
WASHINGTON (dpa-AFX) - Sarepta Therapeutics (SRPT) announced Loss for first quarter that decreased from the same period last year and beat the Street estimates.The company's bottom line came in
Basel, 25 April 2022 Group sales increase 11%1 at constant exchange rates (CER) and 10% in Swiss francsPharmaceuticals Division sales up 6%; continued strong sales of new medicines